FIELD: medicine; cardiology; endocrinology.
SUBSTANCE: present group of inventions concerns prevention of severe adverse cardiovascular event. That is ensured by determining the level of hGH and/or its isoforms in a blood sample of said individual and comparing it with a predetermined threshold value. If the established level of hGH and/or isoform thereof exceeds said predetermined threshold level, the individual is identified as having a vascular risk, which can be reduced by antihypertensive drugs.
EFFECT: this provides stratification of patients for well-timed pharmacotherapy, which, in turn, enables preventing development of severe cardiovascular pathology.
23 cl, 12 tbl, 5 ex, 8 dwg
